{"title":"原发性睫状肌运动障碍诊治实用指南","authors":"Kazuhiko Takeuchi , Miki Abo , Hiroshi Date , Shimpei Gotoh , Atsushi Kamijo , Takeshi Kaneko , Naoto Keicho , Satoru Kodama , Goro Koinuma , Mitsuko Kondo , Sawako Masuda , Eri Mori , Kozo Morimoto , Mizuho Nagao , Atsuko Nakano , Kaname Nakatani , Naoya Nishida , Tomoki Nishikido , Hirotatsu Ohara , Yosuke Okinaka , Shigeharu Fujieda","doi":"10.1016/j.anl.2024.02.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Primary ciliary dyskinesia (PCD) is a relatively rare genetic disorder that affects approximately 1 in 20,000 people. Approximately 50 genes are currently known to cause PCD. In light of differences in causative genes and the medical system in Japan compared with other countries, a practical guide was needed for the diagnosis and management of Japanese PCD patients.</p></div><div><h3>Methods</h3><p>An ad hoc academic committee was organized under the Japanese Rhinologic Society to produce a practical guide, with participation by committee members from several academic societies in Japan. The practical guide including diagnostic criteria for PCD was approved by the Japanese Rhinologic Society, Japanese Society of Otolaryngology–Head and Neck Surgery, Japanese Respiratory Society, and Japanese Society of Pediatric Pulmonology.</p></div><div><h3>Results</h3><p>The diagnostic criteria for PCD consist of six clinical features, six laboratory findings, differential diagnosis, and genetic testing. The diagnosis of PCD is categorized as definite, probable, or possible PCD based on a combination of the four items above. Diagnosis of definite PCD requires exclusion of cystic fibrosis and primary immunodeficiency, at least one of the six clinical features, and a positive result for at least one of the following: (1) Class 1 defect on electron microscopy of cilia, (2) pathogenic or likely pathogenic variants in a PCD-related gene, or (3) impairment of ciliary motility that can be repaired by correcting the causative gene variants in iPS cells established from the patient's peripheral blood cells.</p></div><div><h3>Conclusion</h3><p>This practical guide provides clinicians with useful information for the diagnosis and management of PCD in Japan.</p></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"51 3","pages":"Pages 553-568"},"PeriodicalIF":1.6000,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0385814624000166/pdfft?md5=f2abe3cd797c25551f481310b5c83ab3&pid=1-s2.0-S0385814624000166-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Practical guide for the diagnosis and management of primary ciliary dyskinesia\",\"authors\":\"Kazuhiko Takeuchi , Miki Abo , Hiroshi Date , Shimpei Gotoh , Atsushi Kamijo , Takeshi Kaneko , Naoto Keicho , Satoru Kodama , Goro Koinuma , Mitsuko Kondo , Sawako Masuda , Eri Mori , Kozo Morimoto , Mizuho Nagao , Atsuko Nakano , Kaname Nakatani , Naoya Nishida , Tomoki Nishikido , Hirotatsu Ohara , Yosuke Okinaka , Shigeharu Fujieda\",\"doi\":\"10.1016/j.anl.2024.02.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>Primary ciliary dyskinesia (PCD) is a relatively rare genetic disorder that affects approximately 1 in 20,000 people. Approximately 50 genes are currently known to cause PCD. In light of differences in causative genes and the medical system in Japan compared with other countries, a practical guide was needed for the diagnosis and management of Japanese PCD patients.</p></div><div><h3>Methods</h3><p>An ad hoc academic committee was organized under the Japanese Rhinologic Society to produce a practical guide, with participation by committee members from several academic societies in Japan. The practical guide including diagnostic criteria for PCD was approved by the Japanese Rhinologic Society, Japanese Society of Otolaryngology–Head and Neck Surgery, Japanese Respiratory Society, and Japanese Society of Pediatric Pulmonology.</p></div><div><h3>Results</h3><p>The diagnostic criteria for PCD consist of six clinical features, six laboratory findings, differential diagnosis, and genetic testing. The diagnosis of PCD is categorized as definite, probable, or possible PCD based on a combination of the four items above. Diagnosis of definite PCD requires exclusion of cystic fibrosis and primary immunodeficiency, at least one of the six clinical features, and a positive result for at least one of the following: (1) Class 1 defect on electron microscopy of cilia, (2) pathogenic or likely pathogenic variants in a PCD-related gene, or (3) impairment of ciliary motility that can be repaired by correcting the causative gene variants in iPS cells established from the patient's peripheral blood cells.</p></div><div><h3>Conclusion</h3><p>This practical guide provides clinicians with useful information for the diagnosis and management of PCD in Japan.</p></div>\",\"PeriodicalId\":55627,\"journal\":{\"name\":\"Auris Nasus Larynx\",\"volume\":\"51 3\",\"pages\":\"Pages 553-568\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-03-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0385814624000166/pdfft?md5=f2abe3cd797c25551f481310b5c83ab3&pid=1-s2.0-S0385814624000166-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Auris Nasus Larynx\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0385814624000166\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Auris Nasus Larynx","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0385814624000166","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
Practical guide for the diagnosis and management of primary ciliary dyskinesia
Objective
Primary ciliary dyskinesia (PCD) is a relatively rare genetic disorder that affects approximately 1 in 20,000 people. Approximately 50 genes are currently known to cause PCD. In light of differences in causative genes and the medical system in Japan compared with other countries, a practical guide was needed for the diagnosis and management of Japanese PCD patients.
Methods
An ad hoc academic committee was organized under the Japanese Rhinologic Society to produce a practical guide, with participation by committee members from several academic societies in Japan. The practical guide including diagnostic criteria for PCD was approved by the Japanese Rhinologic Society, Japanese Society of Otolaryngology–Head and Neck Surgery, Japanese Respiratory Society, and Japanese Society of Pediatric Pulmonology.
Results
The diagnostic criteria for PCD consist of six clinical features, six laboratory findings, differential diagnosis, and genetic testing. The diagnosis of PCD is categorized as definite, probable, or possible PCD based on a combination of the four items above. Diagnosis of definite PCD requires exclusion of cystic fibrosis and primary immunodeficiency, at least one of the six clinical features, and a positive result for at least one of the following: (1) Class 1 defect on electron microscopy of cilia, (2) pathogenic or likely pathogenic variants in a PCD-related gene, or (3) impairment of ciliary motility that can be repaired by correcting the causative gene variants in iPS cells established from the patient's peripheral blood cells.
Conclusion
This practical guide provides clinicians with useful information for the diagnosis and management of PCD in Japan.
期刊介绍:
The international journal Auris Nasus Larynx provides the opportunity for rapid, carefully reviewed publications concerning the fundamental and clinical aspects of otorhinolaryngology and related fields. This includes otology, neurotology, bronchoesophagology, laryngology, rhinology, allergology, head and neck medicine and oncologic surgery, maxillofacial and plastic surgery, audiology, speech science.
Original papers, short communications and original case reports can be submitted. Reviews on recent developments are invited regularly and Letters to the Editor commenting on papers or any aspect of Auris Nasus Larynx are welcomed.
Founded in 1973 and previously published by the Society for Promotion of International Otorhinolaryngology, the journal is now the official English-language journal of the Oto-Rhino-Laryngological Society of Japan, Inc. The aim of its new international Editorial Board is to make Auris Nasus Larynx an international forum for high quality research and clinical sciences.